| 產(chǎn)品編號(hào) | 圖片 | CAS No. | 名稱及描述 | 規(guī)格 | 價(jià)格 | 分子式 | 快速訂購(gòu) |
|---|---|---|---|---|---|---|---|
| 200961-1G |
|
4984-22-9 |
(2R)-1-甲氧基-2-丙醇 (2R)-1-Methoxy-2-propanol 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C4H10O2 | |
| 200955-100MG |
|
NA |
(5aS,10bR)-5a,10b-二氫-5-(9-蒽基)-2-(2,4,6-三溴苯基)-4H,6H-茚并[2,1-b][1,2,4]三唑[4,3-d][1,4]惡嗪四氟硼酸鹽 (5aS,?10bR)?-?5a,?10b-?Dihydro-?5-(9-anthracene)-2-(?2,?4,6-?tribromophenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C32H21Br3N3O·BF4 | |
| 200954-100MG |
|
NA |
(5aR,10bS)-5a,10b-二氫-5-(9-蒽基)-2-(2,4,6-三溴苯基)-4H,6H-茚并[2,1-b][1,2,4]三唑[4,3-d][1,4]惡嗪四氟硼酸鹽 (5aR,?10bS)?-?5a,?10b-?Dihydro-?5-(9-anthracene)-2-(?2,?4,6-?tribromophenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C32H21Br3N3O·BF4 | |
| 200953-100MG |
|
NA |
(5aS,10bR)-5a,10b-二氫-5-(9-菲基)-2-((2,6-二溴-4-三氟甲基)苯基)-4H,6H-茚并[2,1-b][1,2,4]三唑[4,3-d][1,4]惡嗪四氟硼酸鹽 (5aS?,?10bR)?-?5a,?10b-?Dihydro-5-?(9-phenanthrene)-2-(?(2,?6-?dibromo-4-trifluoromethyl)phenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C33H21F3Br2N3O·BF4 | |
| 200952-100MG |
|
NA |
(5aR,10bS)-5a,10b-二氫-?5-(9-菲基)-2-((2,6-二溴-4-三氟甲基)苯基)-4H,6H-茚并[2,1-b][1,2,4]三唑[4,3-d][1,4]惡嗪四氟硼酸鹽 (5aR,?10bS)?-?5a,?10b-?Dihydro-?5-(9-phenanthrene)-2-(?(2,?6-?dibromo-4-trifluoromethyl)phenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C33H21F3Br2N3O·BF4 | |
| 200937-100MG |
|
NA |
(5aS,10bR)-5a,10b-二氫-5-(1-萘基)-2-(2,4,6-三溴苯基)-4H,6H-茚并[2,1-b][1,2,4]三唑[4,3-d][1,4]惡嗪四氟硼酸鹽 (5aS,?10bR)?-?5a,?10b-?Dihydro-?5-(1-naphthalene)-2-(?2,?4,6-?tribromophenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C28H19Br3N3O·BF4 | |
| 200951-100MG |
|
NA |
(5aR,10bS)-5a,10b-二氫-5-(1-萘基)-2-(2,4,6-三溴苯基)-4H,6H-茚并[2,1-b][1,2,4]三唑[4,3-d][1,4]惡嗪四氟硼酸鹽 (5aR,?10bS)?-?5a,?10b-?Dihydro-?5-(1-naphthalenyl)-2-(?2,?4,6-?tribromophenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C28H19Br3N3O·BF4 | |
| 200936-100MG |
|
NA |
(5aS,10bR)-5a,10b-二氫-5-苯基-2-(2,4,6-三溴苯基)-4H,6H-茚并[2,1-b][1,2,4]三唑[4,3-d][1,4]惡嗪四氟硼酸鹽 (5aS,?10bR)?-?5a,?10b-?Dihydro-?5-phenyl-2-(?2,?4,6-?tribromophenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C24H17Br3N3O·BF4 | |
| 200950-100MG |
|
NA |
(5aR,10bS)-5a,10b-二氫-5-苯基-2-(2,4,6-三溴苯基)-4H,6H-茚并[2,1-b][1,2,4]三唑[4,3-d][1,4]惡嗪四氟硼酸鹽 (5aR,?10bS)?-?5a,?10b-?Dihydro-?5-phenyl-2-(?2,?4,6-?tribromophenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C24H17Br3N3O·BF4 | |
| 200935-100MG |
|
NA |
(5aS,10bR)-5a,10b-二氫-2-((2,6-二溴-4-三氟甲基)苯基)-4H,6H-茚并[2,1-b][1,2,4]三唑[4,3-d][1,4]惡嗪四氟硼酸鹽 (5aS?,?10bR)?-?5a,?10b-?Dihydro-?2-(?(2,?6-?dibromo-4-trifluoromethyl)phenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C19H13F3Br2N3O·BF4 | |
| 200949-100MG |
|
NA |
(5aR,10bS)-5a,10b-二氫-2-((2,6-二溴-4-三氟甲基)苯基)-4H,6H-茚并[2,1-b][1,2,4]三唑[4,3-d][1,4]惡嗪四氟硼酸鹽 (5aR,?10bS)?-?5a,?10b-?Dihydro-?2-(?(2,?6-?dibromo-4-trifluoromethyl)phenyl)?-4H,?6H-?indeno[2,?1-?b]?[1,?2,?4]?triazolo[4,?3-?d]?[1,?4]?oxazinium Tetrafluoroborate 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C19H13F3Br2N3O·BF4 | |
| 200929-25G |
|
133170-58-8 |
D-纈氨酰胺鹽酸鹽 D-Valinamide Hydrochloride 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
25G | 需詢價(jià) | C5H12N2O?HCl | |
| 200929-5G |
|
133170-58-8 |
D-纈氨酰胺鹽酸鹽 D-Valinamide Hydrochloride 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
5G | 需詢價(jià) | C5H12N2O?HCl | |
| 200929-1G |
|
133170-58-8 |
D-纈氨酰胺鹽酸鹽 D-Valinamide Hydrochloride 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C5H12N2O?HCl | |
| 200927-1G |
|
NA |
(S)-6,6'-雙[(3,5-二叔丁基)苯基]螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
1G | 需詢價(jià) | C45H55O4P | |
| 200927-100MG |
|
NA |
(S)-6,6'-雙[(3,5-二叔丁基)苯基]螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價(jià) | C45H55O4P | |
| 200927-25MG |
|
NA |
(S)-6,6'-雙[(3,5-二叔丁基)苯基]螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價(jià) | C45H55O4P | |
| 200926-1G |
|
NA |
(R)-6,6'-雙[(3,5-二叔丁基)苯基]螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
1G | 需詢價(jià) | C45H55O4P | |
| 200926-100MG |
|
NA |
(R)-6,6'-雙[(3,5-二叔丁基)苯基]螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價(jià) | C45H55O4P | |
| 200926-25MG |
|
NA |
(R)-6,6'-雙[(3,5-二叔丁基)苯基]螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價(jià) | C45H55O4P | |
小泰
|
010-60710855
|